All studies
AuthorisedTherapeutic exploratory (Phase II)Interventional

Multicenter, randomized, open-label non-inferiority trial, comparing two antibiotic therapy periods (3 versus 7 days) in patients with mild leptospirosis and seen at the hospital in 5 French overseas departments (Martinique, Guadeloupe, French Guiana, Reunion, Mayotte)

Leptospirosis is an infection caused by bacteria found in water or soil that has been contaminated by animal urine. People with mild cases often need hospital treatment and are usually given antibiotics for seven days. This clinical study is testing whether a shorter, three-day course of antibiotics is just as safe and effective as the usual seven-day course. Patients who take part will be placed into one of two groups: one receiving antibiotics for three days, and the other receiving them for seven days. Doctors will monitor everyone closely for three weeks. They will check body temperature, run blood tests, and watch for any complications to make sure the infection clears completely. Shorter antibiotic courses can lower the risk of side effects, reduce time spent on medication, and help prevent bacteria from becoming resistant to treatments.

At a glance

Status
Authorised
Phase
Therapeutic exploratory (Phase II)
Sponsor
CHU De Martinique
Enrolment target
304
Start
13 Aug 2026

What is this study about?

Leptospirosis is an infection you can catch if contaminated water or soil enters your eyes, mouth, or cuts on your skin. It is caused by bacteria commonly carried by animals like rats. In mild cases, people often develop flu-like symptoms such as high fever, headache, muscle aches, and chills. While many people recover well, the infection still requires prompt antibiotic treatment in hospital to prevent it from causing serious damage to the kidneys, liver, or lungs.

Currently, standard care often involves taking antibiotics for about seven days. However, doctors are investigating whether a shorter course of just three days is enough to clear the infection. Shorter treatments are easier for patients to complete, reduce the chance of common side effects like stomach upsets, and help prevent bacteria from adapting and becoming resistant to antibiotics over time.

This study compares the two treatment lengths directly. Researchers will closely watch patients in both groups to see if those on the three-day course recover just as quickly and thoroughly as those on the seven-day course. By tracking fever, blood counts, and organ function, the study aims to prove that shorter treatment is just as safe without increasing the risk of the illness returning.

Key takeaways

  • The trial tests whether 3 days of antibiotics works as well as 7 days for mild leptospirosis.
  • Participants are randomly chosen to receive either the shorter or standard course.
  • Common, approved antibiotics like doxycycline and amoxicillin are used.
  • Patients are monitored closely with blood tests and temperature checks for 21 days.
  • Taking part is voluntary, and participants can withdraw at any time.

Who may be eligible?

This study is open to adults aged 18 and over who have been diagnosed with mild leptospirosis and are being cared for in a participating hospital. Both men and women can take part.

People who already have severe complications from leptospirosis—such as severe breathing difficulties, kidney failure, or very low blood pressure—will not be eligible, as they require urgent, specialised intensive treatment. People who have severe allergies to the antibiotics used in the trial (such as amoxicillin, doxycycline, or ceftriaxone) may also be unable to join.

A doctor at the hospital will carry out standard blood tests and an examination to confirm if the infection is mild and whether taking part is safe and suitable for each individual.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

  1. I am aged 18 or older.
  2. I have been diagnosed with mild leptospirosis at the hospital.
  3. I do not have severe organ damage, kidney failure, or dangerously low blood pressure.
  4. I am able to safely take common antibiotics like penicillin or doxycycline.
Answer every question to see your result.

What does participation involve?

If you take part, you will be randomly assigned by a computer to receive antibiotics for either 3 days or 7 days. The antibiotics used are standard medicines—such as amoxicillin or doxycycline—given as tablets or through a small drip into a vein. During your hospital stay and for the first week, the medical team will check your temperature, heart rate, and blood pressure regularly, and will take blood samples to check your liver, kidneys, and blood counts. You will also have follow-up reviews up to day 21 to ensure you have no lingering symptoms like sickness, joint pain, or yellowing of the skin (jaundice), and you will be asked to fill in a simple questionnaire about how you are feeling. Your total time in the study will be about three weeks.

Potential risks and benefits

Taking part may mean you receive a shorter course of medicine, which can reduce your risk of common antibiotic side effects like nausea or diarrhoea. You will also receive very close medical observation from the hospital research team. However, there is a risk that a three-day course may not be long enough for everyone, which could cause a fever or other symptoms to return. If this happens, doctors will step in immediately to give you extra treatment. You can choose to leave the study at any time without giving a reason, and your regular medical care will not be affected.

Locations (1)

Some site locations are approximate. We're improving this — please verify with the trial team before travelling.
  • —
    Unverified
    France

Common questions

What is leptospirosis?

It is a bacterial infection spread through contact with soil or fresh water contaminated by the urine of infected animals, especially rodents.

Why are researchers testing a shorter course?

Shorter courses of antibiotics can reduce side effects, make treatment simpler, and lower the chances of bacteria becoming resistant to essential medicines.

Can I choose whether I get 3 or 7 days of treatment?

No. A computer system decides your treatment length at random to ensure the results of the comparison are completely fair and unbiased.

What happens if my infection does not clear up?

Your medical team will monitor you closely every day. If your fever returns or you show signs of worsening, doctors will give you further standard antibiotics right away.

Will taking part cost me anything?

No. The study medications and all trial-related tests are provided at no extra cost to you.

How to find out more

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.